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Abstract
Background This study assessed the prevalence of gastroesophageal reflux disease (GERD) in a general adult population
from Temuco in southern Chile. The association of GERD with demographic variables was also examined.
Methods A cross-sectional study among the general population of Temuco in southern Chile was conducted in 2017, using a
validated and reliable questionnaire for detecting GERD. The urban area of Temuco, with a population of 245,317 inhabitants
(2002 census), was divided into four zones, which were representative of the socioeconomic sectors of the city. The sample
size was estimated assuming a prevalence of 52.8%, an accuracy of 3.0%, a confidence level of 95.0%, and a design effect of
1.15. Area sampling was used to build clusters. The prevalence of GERD was determined and associated factors were studied
by means of bivariate and multivariate analyses.
Results A total of 1,069 subjects (47.9% women, median age 40 years) from the selected subareas were interviewed. The prev-
alence of GERD was 44.8%. The most frequently reported symptom was regurgitation (54.8%). One-third of subjects took
medication to control symptoms and was considered ‘sick’ by the instrument, although >68% of them had never sought
medical consultation. There was a significant association between GERD and age (P<0.001) and female gender (P¼0.001).
Conclusions In this population-based study, the prevalence of GERD was high (44.8%). GERD was associated with age and fe-
male gender.
Key words: gastroesophageal reflux disease; prevalence; cross-sectional studies; evidence-based medicine; clinical
epidemiology
Introduction
Gastroesophageal reflux disease (GERD) is a frequent cause of
consultation. Typical symptoms, such as heartburn and regurgi-
tation are common in the community, occurring in up to 33% of
the adult population. It has been estimated that 30% of
symptomatic subjects have esophagitis and that 70% require
regular treatment for the control of symptoms, which can
strongly affect their quality of life [1]. There are a few reports on
the prevalence of GERD in the general population and most
studies have been conducted in specific [2–6] or mixed
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populations [7–9], such as elderly subjects [2], pregnant
women [3], and subjects with type 2 diabetes [4], asthma [5], or
depressive disorder [6]. Many questionnaires used to assess
the prevalence of GERD are not reproducible or have not been
previously validated [2–4, 9–17]. Also, the survey approach,
including telephone interviews, postal questionnaires, and self-
completed instruments, has methodological limitations [3, 11,
12, 14, 16–25].
Therefore, to overcome these limitations, we conducted a
population-based study to assess the prevalence of GERD in the
general adult population of Temuco, a city in southern Chile,
using a validated and reliable questionnaire specific for reflux
disease [26]. Data of previous prevalence studies of GERD using
face-to-face interviews were compared with findings of our
study. The objective of our study was to determine GERD preva-
lence in a general adult population from Temuco in southern
Chile and its association with demographic variables.
Materials and methods
Data source
The source population consisted of all individuals 18 years or
older living in the urban area of Temuco, Chile, between 1
March 2017 and 31 December 2017. According to Chile’s
Institute of Statistics (INE), the total urban population of the city
was 232,528 inhabitants, of whom 172,116 subjects were adults
(>18 years of age) [27].
Study design and participants
A cross-sectional survey was designed, the primary objective of
which was to determine the prevalence of GERD in the adult ur-
ban population of Temuco. Secondary objectives were: (i) to de-
scribe clinical features and associated factors of patients with
GERD and (ii) to assess demographic, anthropometric, and so-
ciocultural factors of respondents to the survey. Subjects of
both sexes, aged 18 years or older who gave written informed
consent, were included in the study. Exclusion criteria were as
follows: morbid obesity, scleroderma, pulmonary disease, pres-
ence of neoplasms, esophageal motor disorders, diseases capa-
ble of causing GERD or alterations in esophageal motility as part
of its natural history, benign and malignant gastroduodenal dis-
eases, history of surgery of the upper gastrointestinal tract, and
caustic injury. Pregnant women and subjects with cognitive im-
pairment or mental illness were also excluded.
Study procedures
A validated and reliable specific questionnaire for the diagnosis
of GERD was used [26, 28]. The questionnaire consists of seven
items: heartburn, regurgitation, chest pain, dry cough, dyspha-
gia, dysphonia, and asthma. Heartburn, regurgitation, chest
pain, and dry cough are scored from 0 to 3 (0: none; 1: at least
once a month; 2: at least once a week; 3: every day) and dyspha-
gia, dysphonia, and asthma from 0 (absent) to 1 (present), with a
total score from 0 to 15. The questionnaire has been previously
validated against the results of 24-hour esophageal pH monitor-
ing and showed an internal consistency of 0.75 and inter-ob-
server reliability of 0.87 [28]. Using a cut-off score of 3, the
sensitivity, specific, positive, and negative predictive values
were 92%, 95%, 98%, and 79%, respectively, with a correct classi-
fication of subjects of 92.4% [26, 28]. Other data of interest were
added to the questionnaire, including age and gender, anthro-
pometric data (height, weight, and body mass index [BMI]),
tobacco and alcohol consumption, medications used for the
control of GERD symptoms, and use of healthcare resources for
GERD-related consultations.
Sampling and administration of the questionnaire
The urban area of Temuco was divided into four sectors, which
were representative of different economic and cultural areas of
the city, e.g. sectors 1 and 2 are of medium social and economic
status, sector 3 of high status, and sector 4 of low status
(Figure 1). The downtown district was excluded because most of
the buildings were commercial properties or office spaces.
Sectors were then divided into 12 subsectors of approximately
clusters of 10 blocks each. A two-stage cluster random-sampling
method was used, in which a subset of households within each
selected conglomerate of blocks was randomly selected for in-
clusion in the study (Figure 2). A team of six previously trained
medical students performed face-to-face interviews in the se-
lected households. They also confirmed the eligibility criteria,
obtained the written informed consent, and administered the
questionnaire. Interviewers were totally familiar with the in-
strument and knew how to explain better any eventual ques-
tion that has not been fully understood by the subjects
interviewed. When no one fulfilled the inclusion criteria, the
household on the right of the index home was selected. When
no one lived in the household, the interviewer returned
24 hours later and, if it was still uninhabited, it was replaced by
the contiguous household on the right. Respondents who,
according to the scale, were found to suffer from GERD were re-
ferred to the healthcare center for further consultation.
Ethical consideration
The study was approved by the Ethics Committee of the
Universidad de La Frontera. Written informed consent was
obtained from all participants. Personal data were anonymized.
This manuscript was written following the STROBE statement.
Sample size and statistical analysis
Considering that the urban adult population of Temuco is
172,116 inhabitants [27] and based on a prevalence of GERD of
52.8% found in a previous pilot study of our group [29], with an
accuracy of 3.0%, a confidence interval of 95%, and a design
Figure 1. Map of Temuco used for further cluster randomization. Temuco was
divided into four sectors properly representing the various economic and cul-
tural areas of the city. Cluster randomization of sector 1 can be seen. The boxes
in bold represent the subsectors studied.
Gastroesophageal reflux disease prevalence | 287
effect of 1.15, a sample size of 1,057 subjects was calculated.
Categorical variables are expressed as frequencies and percen-
tages, and continuous variables as mean and standard devia-
tion or as median and range. The prevalence of GERD and the
prevalence of individual symptoms of reflux disease were calcu-
lated. The chi-square test and the Fisher’s exact test were used
for the comparison of categorical variables, and the Mann–
Whitney U test or the Wilcoxon test for the comparison of con-
tinuous variables. Multiple logistic-regression analysis was
used to assess variable independently associated with GERD.
Statistical significance was set at P< 0.05.
Results
A total of 1,069 subjects were interviewed (47.9% women) with a
median age of 40 years (range 18–92 years). The average BMI was
25.764.4 kg/m2 (range 15.8–54.1 kg/m2). Education level in-
cluded primary education in 18.1% of subjects, secondary edu-
cation in 47.0%, and university studies in 34.3%. Six people
(0.6%) were illiterate. Current smoking was recorded in 5.5% of
subjects and alcohol consumption in 3.0%. Working status in-
cluded active workers in 45.5% of subjects, housewives in 17.2%,
pensioners/retired in 6.0%, unemployed in 3.0%, and students in
28.2%.
The median overall score of the in-study population was 2
(range 0–13) and the average score was 2.76 2.6. On the other
hand, 590 subjects (55.2%) had a score of <3 (average 0.96 0.8)
and 479 subjects (44.8%) had a score of 3 (average 5.16 2.1). So,
the prevalence of GERD was 44.8%. The prevalence of GERD var-
ied according to areas surveyed (Table 1), but differences were
not statistically significant. On the other hand, regurgitation
was the most frequently reported symptom (54.8%) followed by
heartburn (31.3%), cough (30.4%), and chest pain (29.8%)
(Table 2).
About one-third of respondents (n¼ 353) with GERD scoring
3 in the questionnaire reported that they were using medica-
tions to control GERD symptoms, including antacids in 41.9% of
cases, H2 antagonists in 30.9%, and PPIs in 26.9% (no relation-
ship between positivity questionnaire and PPIs use was veri-
fied). Drugs had been prescribed by a healthcare professional in
only 53.0% of subjects (n¼ 187). Also, 68.0% of these subjects
(n¼ 240) never visited the public healthcare system (55.0% were
visited in private practices, 27.5% self-medicated, 14.2% chose
alternative medicines, and the remaining 3.3% did not respond
to this item).
In the bivariate analysis, the prevalence of GERD was higher
in women than in men (64.3% vs 26.9%, P< 0.001). Also, subjects
with GERD were older and shorter (Table 3). In the multivariate
analysis, age (P< 0.001) and female gender (P¼ 0.001) were the
variables independently associated with GERD.
Discussion
The present population-based study carried out in the city of
Temuco, Chile has shown a prevalence of GERD of 44.8%. We
used a reliable and validated questionnaire for assessing esoph-
ageal reflux disease according to the presence and frequency of
seven common symptoms of GERD. The prevalence found in
the present study is lower than that observed in a previous
Figure 2. Sampling of subsector 8 of sector 1. Maps were raised to later randomize blocks and households.
Table 1. Distribution of the prevalence of gastroesophageal reflux
disease (GERD) in the population surveyed from the four sectors of
the city
Sector No. of subjects Presence of GERD, n (%)
1 361 142 (39.3)
2 232 128 (55.2)
3 231 114 (49.3)
4 245 95 (38.8)
Total 1,069 479 (44.8)
Table 2. Distribution of symptoms of gastroesophageal reflux dis-
ease (GERD) in the population surveyed (n¼ 1,069)
Symptom No. of subjects (%)
Heartburn 335 (31.3)
Regurgitation 586 (54.8)
Chest pain 258 (24.1)
Dry cough 318 (29.8)
Dysphagia 325 (30.4)
Dysphonia 241 (22.5)
Asthma 159 (14.9)
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cross-sectional survey (52.8%) in 2002–2003 in the same city, al-
though, in this case, only 364 persons were interviewed [29]. A
review of prevalence studies of GERD in adult populations using
face-to-face interviews and published from 2000 is summarized
in Table 4 [15, 29, 30, 32–36, 38–40]. Prevalence rates are highly
variable from 3.5% to 52.8% as well as the number of subjects in-
cluded in the surveys (from 364 to 13,959) and the geographical
origin of the study samples. In these studies, the GerdQ ques-
tionnaire developed by Jones et al. [41] and the GERD question-
naire developed by Locke et al. [31] were the tools most
frequently used for diagnosing GERD. In some surveys, how-
ever, the prevalence of GERD was defined as the presence of
acid regurgitation and/or heartburn at least once a week [33, 37].
Marked differences in the prevalence rates of GERD have been
reported in populations from Asia (between 1.7% and 27.5%) [25,
32–37, 40], Europe (between 14.8% and 28.7%) [16, 20, 42], and
Latin America (between 4.7% and 52.8%) [22, 29, 30].
The comparison across studies is limited, for different rea-
sons: the heterogeneity of the in-study populations and the use
of different scales and instruments with the same purpose, but
only some of them valid and reliable [26, 31, 41]. On the other
hand, there are a lot of studies using different definitions of
GERD and utilizing ‘unknown questionnaires’ as measurement
instruments. The majority of published instruments (almost 40)
did not fulfill all relevant diagnostic criteria [43]. Finally, other
reasons that may be associated are the form of applying the
measurement instruments (face to face, by phone, mail, etc.),
the accuracy of the sample-size estimation, the type of sam-
pling strategies utilized, etc.
A high prevalence of main GERD symptoms was found in
our study, particularly heartburn and regurgitation, although
this finding is consistent with the high number of subjects who
reported taking anti-reflux medications for the control of symp-
toms, generally prescribed by the public healthcare system.
Also, age, female gender, and height were associated with
GERD. A relationship of GERD with increasing age has also been
reported in other studies [20, 33, 40]. It has been shown that
non-erosive reflux disease is more common in women, whereas
Barrett’s esophagus and esophageal adenocarcinoma are more
frequent in men [44]. The estrogen-related endocrine milieu is
reported to modulate the metabolism of fat and obesity is a
main risk for GERD [45].
Obesity and BMI are well-known risk factors for reflux dis-
ease (especially in the Western population). This association is
not coincidental because GERD pathophysiology is, in part, con-
nected with overweight and obesity [17, 38, 45–47]. A relation-
ship between BMI and GERD was not observed probably because
one of the exclusion criteria of our study was obesity, in spite of
which, the study population was slightly overweight (the BMI
average was 25.764.4 kg/m2, with a fairly similar distribution
across the four sectors). The average of <3 and 3 points
subgroups were 25.66 3.9 and 26.86 4.9 kg/m2, respectively
(P¼ 0.1619). Related to any dietary elements in this geographical
area of Chile that could lead to obesity, we can argue that effec-
tively there are some, e.g. the fruit of the araucarias (La
Araucanı´a Region typical tree), called ‘pi~nones’; however, there
is not enough evidence to asseverate it.
We did not find differences in other factors that have been
related to the disease, such as smoking or alcohol consumption
[48, 49]. The small percentage of smokers and alcohol users in
our study may account for this finding. On the other hand, the
proportion of subjects with university studies was 34.3%—a
high rate that can be explained by the presence of numerous ed-
ucation centers in two areas of the city. The percentage of un-
employed patients was also high because students accounted
for 28.0% of the study sample. An influence of the education
level or working status on the development of GERD was not
established. After logistic-regression analysis, only age and fe-
male gender were significantly associated with GERD.
The potential effect of indigenous elements in the popula-
tion samples is difficult to determine precisely because, al-
though the self-declared indigenous population in urban
Temuco in the 2017 census was 24.7% (including different races
of original peoples) [50], there is no form to determine the pro-
portion of indigenous elements in the different in-study sectors
(possibly this value can be even higher, because there are peo-
ple with indigenous ancestry who are not considered as such).
On the other hand, regarding the potential influence of
migrants from rural communities around introducing higher
Helicobacter pylori rates and hence less GERD, there is evidence
supporting no relationship between GERD and H. pylori pres-
ence; also, successful eradication therapy does not have an im-
pact on the emergence or exacerbation of GERD [51–54].
Another interesting point to comment on is the potential as-
sociation between the high rates of GERD and esophageal can-
cer (Barrett’s-related) rates in the community. First of all, we do
not know the reasons to explain the high prevalence of GERD
found, but it is similar to a previous study published in 2005
[29]. On the other hand, the crude mortality rate of esophageal
cancer per 100,000 inhabitants in Chile in 2015 was 3.7.
However, in La Araucanı´a Region (Capital Temuco), it was 9.5
for men and 6.2 for women (the highest in the country) [55], so
is a fascinating issue for further investigation. However, Barrett
esophagus in our city has unknown incidence.
The present findings should be interpreted taking into ac-
count the limitations of the study, particularly the generalizabil-
ity of the results to different target populations. The strengths
of the study include the use of a validated and reliable question-
naire for assessment of GERD symptoms, trained interviewers,
the face-to-face approach for administering the questionnaire,
and the cluster random sampling for the selection of
participants.
In conclusion, using a population-based cross-sectional
study and a validated questionnaire, the prevalence of GERD in
an urban area of southern Chile was 44.8%. An independent as-
sociation of GERD with female gender and age was observed.
Further studies using endoscopic examination would be neces-
sary to ascertain the association between a positive question-
naire score for GERD and endoscopic esophagitis. In addition, it
would be advisable to carry out education campaigns to detect
and treat patients with GERD in order to prevent complications
and to contribute to reducing the economic burden of the
disease.
Table 3. Association between demographic variables and gastro-
esophageal reflux disease (GERD)
Variable No GERD (n¼ 590) GERD (n¼ 479) P-value
Age, years 40.7 6 18.0 45.7 6 18.0 <0.001
Sex, n (%) <0.001
Female 183 (35.7) 329 (64.3)
Male 407 (63.1) 150 (26.9)
Height, cm 164.1 6 13.6 161.66 12.5 0.047
Weight, kg 68.7 6 12.5 68.6 6 12.7 0.942
Body mass index, kg/m2 25.6 6 3.9 26.8 6 4.9 0.162
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